在血液透析患者中调节的肝素和铁生物标志物
M Mohammed1, E Sarhat2, M Marbut2
11Kirkuk Health Directorate, Iraq.
Georgian medical news
|January 18, 2024
概括
在患有慢性脏病 (CKD) 的血液透析患者中,血清肝素和铁素水平显著升高,这表明潜在的炎症和铁失调. 这些水平在透析后下降,这表明它在CKD相关并发症中的作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 生物化学 生物化学
背景情况:
- 慢性病 (CKD) 是一种影响功能和结构的普遍疾病,通常与其他健康问题同时发生.
- 炎症和铁代谢失调是经过血液透析 (HD) 的CKD患者的常见并发症.
- 血清肝素是铁稳态的关键调节剂,与炎症过程有关.
研究的目的:
- 研究血清肝素在慢性病 (CKD) 的血液透析患者的炎症中的作用.
- 为了比较经过血液透析的CKD患者的血清肝素水平与健康对照人群.
- 在CKD患者中探索血清肝素和其他生化标志物之间的相关性.
主要方法:
- 一项基于医院的前性研究,涉及30名经常接受血液透析的CKD患者和30名健康对照.
- 使用酶相关免疫吸收试验 (ELISA) 测量血清肝素水平.
- 还分析了血清铁和铁总结合能力 (TIBC).
主要成果:
- 与对照组相比,血液透析患者的血清肝素和费里丁水平显著提高.
- 血清铁和TIBC在HD患者中的水平低于对照组.
- 血清肝素水平在血液透析后下降,与费里丁,尿素和肌素正相关,与血清铁和血红蛋白负相关.
结论:
- 在血液透析患者中血清肝素和费里丁的升高表明它们在CKD中与炎症和铁代谢失调有关.
- 肝素水平似乎受到血液透析治疗的影响.
- 需要进一步的研究来阐明肝素在CKD相关炎症中的精确机制和临床影响.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
93
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
01:11Renal Failure: Dose Adjustments
92
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
92
01:27Dialysis
319
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
319